Nothing concrete to my knowledge, in H1 2018 is all I have as a 'confirmation' (from VLA CFO, about a month ago) but I do remember something about April 2018 (possibly for the 2018 ACCR conference, which we're now not presenting @ this year, but instead, we're doing '2018 International Oncolytic Virus Conferenc' in Oxford, UK, 9-12 April, so maybe it's then/there, which is Glasko's (GSK) backyard from memory), being the next 'scheduled release' of data, for KEYNOTE-200 & MITCI definitely, if not also the others in play...
April is approaching swiftly, so hopefully, so are the results...
ML
VLA Price at posting:
$1.68 Sentiment: Hold Disclosure: Held
